Product marketing drives medical adoption through evidence-based positioning and outcome-focused messaging. We turn clinical validation into positioning that patients, providers, and buyers actually act on.
The Problem
Clinical validation does not translate into positioning that patients, providers, and institutional buyers respond to
Most health and wellness companies can point to strong clinical data but describe it the same way in a sales deck, a patient app screen, and a hospital procurement packet. Each audience needs the evidence framed differently: providers want mechanism and comparative outcomes, patients want plain-language benefit, payers want cost offset. Companies that market clinical evidence in one voice lose adoption to less rigorous products that simply communicate better to each audience.
FDA advertising rules and clinical claim substantiation cut off the differentiation tactics that work in other categories
Comparative claims, before/after framing, and superlative language that a consumer or SaaS product marketer would reach for first can trigger an FDA warning letter or misbranding risk in health and wellness. Marketing teams built on consumer playbooks either overclaim and create legal exposure, or under-claim and blend into the category. The fix is not fewer claims – it's building positioning that gets its power from evidence structure, not adjectives.
Health buying decisions run through multiple stakeholders with different evidence bars and timelines than a typical B2B sale
A single sale can require separate buy-in from a clinician, a procurement or compliance officer, and in some cases a payer – each on a different evaluation clock, sometimes stretching past six months. A product marketing plan built for a single decision-maker collapses under that structure: messaging built for the clinician doesn't answer the procurement officer's questions, and the deal stalls waiting on evidence nobody prepared.
How We Help
We start by pulling apart the clinical evidence itself – published studies, outcome data, regulatory clearances – and mapping which claims are strong enough to lead with and which need softer framing. This is the step most health marketing skips, and it's why so much positioning in this category reads as generic wellness copy instead of something backed by data. From there we build separate messaging tracks for each stakeholder in the buying chain: a provider track built on mechanism and comparative outcomes, a patient track built on plain-language benefit, and where relevant a payer or administrator track built on cost and utilization impact.
These tracks stay consistent on the underlying claim but differ in how much evidence detail and what proof format each audience needs. Every claim gets checked against FDA advertising guidance and substantiation requirements before it ships, so differentiation comes from evidence structure and specificity, not from claims that create legal exposure. On the go-to-market side, we work directly with your clinical and regulatory teams rather than handing them a finished deck to sign off on – that catches accuracy problems before launch instead of after a provider or reviewer flags them.
The result is positioning that a clinician would not push back on and a patient can actually understand, tied to the sales and marketing motion that has to carry it into a six-to-twelve-month buying cycle.
What we deliver
- Clinical evidence audit – a ranked map of which published data, outcome measures, and regulatory clearances are strong enough to lead with in positioning
- Stakeholder messaging tracks – separate, claim-consistent messaging built for clinicians, patients, and payers or administrators, each matched to what that audience needs to see proof of
- Compliance-checked claims library – positioning language reviewed against FDA advertising and substantiation requirements before it reaches a deck, page, or ad
- Buying-cycle GTM plan – marketing assets sequenced to the actual multi-stakeholder evaluation timeline instead of a single-decision-maker funnel
- Clinical and regulatory sign-off loop – a working review cadence with your internal teams so accuracy issues get caught before launch, not after
Health product marketing fails when it leads with features instead of evidence. The positioning that actually moves adoption is built on which claims a clinician will not push back on – not on how compelling the copy sounds.
Our Methodology
We run a 90-day cycle. Weeks 1-2: clinical evidence audit and stakeholder mapping – what data exists, what each buyer in the chain needs to see, and where the current positioning is over- or under-claiming. Weeks 3-6: build the stakeholder messaging tracks and run every claim through compliance review alongside your regulatory team. Weeks 7-12: launch the GTM assets and sequence them to the real buying timeline, then start tracking which claims are landing with which audience. The difference from a standard product marketing engagement: we start from what the evidence supports, not from a positioning workshop, and we measure success by adoption movement in each stakeholder segment – not by campaign engagement metrics that don't map to a clinical buying decision.
How We Work
First 30 days: the clinical evidence audit and stakeholder mapping described above, done alongside whoever on your team owns clinical and regulatory sign-off. Weeks 5-8: we build and compliance-check the messaging tracks and the GTM sequence. Weeks 9-12: launch and first-read on adoption movement by stakeholder segment. You provide the clinical data, product access, and target account or market list; we run the evidence work, the messaging build, and the compliance coordination. The team on our side is a strategist with direct healthcare marketing and regulatory-adjacent experience – not a generalist account lead. Monthly reporting covers stakeholder-level engagement, which claims are converting versus stalling, and where the buying cycle is bottlenecking. Engagements typically run 6-12 months because that's how long a real clinical buying cycle takes to move through, with the option to extend into ongoing positioning maintenance as new evidence or clearances come in.
- Clinician-facing message adoption
- Patient comprehension and conversion
- Faster movement through multi-stakeholder buying cycles
- Reduced compliance rework on claims
If your health & wellness company needs product marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does product marketing cost for health and wellness companies?
Engagements typically run $22K-45K per month, scaled to how many stakeholder segments you're marketing to and how much regulatory coordination the claims require. A company selling only to consumers sits at the lower end; one selling into clinical and institutional channels with FDA-regulated claims sits higher. Compare that to hiring a dedicated in-house product marketer with healthcare experience, which usually costs more once you add benefits and ramp time, without the regulatory-review muscle built in.
How long before we see results from health product marketing?
Clean, compliance-checked positioning is usually in place within 60-90 days. Measurable engagement from providers or patients on the new messaging typically shows up in months 3-4. Because most health buying cycles run six months or longer, adoption and pipeline movement that you can attribute to the new positioning tends to show up clearly in months 6-12, not before.
How does your team work with our clinical and regulatory staff?
Our strategist works directly with whoever owns clinical validation and regulatory review on your team, not around them. Every claim goes through that review before it ships in a deck, page, or ad. That loop is built into the 90-day cycle from week one, so it's not a bottleneck added at the end – it's how the messaging gets built in the first place.
What makes Winston Francois different from a traditional product marketing agency?
Most agencies apply the same consumer or SaaS positioning playbook to a health product and either overclaim into compliance risk or flatten the message into generic wellness language. We start from the clinical evidence and build positioning that survives regulatory review because it was built with that review in mind, not bolted onto it afterward.
How do you measure ROI from health product marketing?
We track adoption by stakeholder segment – clinician response to the provider-facing messaging, patient conversion on the consumer-facing messaging, and where deals stall in a multi-stakeholder buying cycle. Those are the numbers that tell you if the positioning is working, not general engagement metrics that don't map to a clinical purchase decision. You'll see this broken out in monthly reporting, not as a single blended score.
What type of health and wellness company is the right fit for this?
Companies with clinically validated products that are struggling to get that validation to land with providers, patients, or institutional buyers – medical device makers, health tech platforms, digital therapeutics, and clinical software providers most often. If you don't yet have real clinical or outcome data to build from, the first move is generating that evidence, not marketing around its absence.
